Actively Recruiting
SwissTAVI Registry
Led by Insel Gruppe AG, University Hospital Bern · Updated on 2024-05-23
20000
Participants Needed
2
Research Sites
743 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this prospective multi-center, observational national registry in Switzerland is to obtain clinical baseline, procedural and follow-up data of all patients treated with TAVI in Switzerland and to assess short, mid- and long-term clinical outcome data of the CE approved devices. All centers in Switzerland implanting the CE approved devices for TAVI will be invited to include patients in the registry. Each site will collect baseline and procedural data as well as clinical outcome data up to five years.
CONDITIONS
Official Title
SwissTAVI Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Native aortic valve stenosis
- Native aortic valve regurgitation
- Degenerated aortic bioprosthesis requiring treatment
You will not qualify if you...
- Patient refuses informed consent to participate in the registry
- Contraindication for TAVI
- High probability of non-adherence to the follow up requirements
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Department of Cardiology
Bern, Switzerland, 3010
Actively Recruiting
2
Department of Cardiology
Bern, Switzerland, 3010
Actively Recruiting
Research Team
S
Stefan Stortecky, MD
CONTACT
S
Stephan Windecker, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here